Development, Validation and Green Analytical Assessment of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Glycopyrronium, Vilanterol and Fluticasone Furoate in Capsule Dosage Form
For simultaneous evaluation of glycopyrronium, vilanterol, and fluticasone furoate in capsules, an Inertsil ODS C18 column was used to develop a reverse-phase HPLC technique that was stability-indicating and sufficient for pharmacopeial quality control of the marketed formulation.